Invesco NASDAQ Biotechnology ETF
IBBQ
9 hedge funds and large institutions have $15.9M invested in Invesco NASDAQ Biotechnology ETF in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 9 → 9 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
37.35% less ownership
Funds ownership: 92.63% → 55.28% (-37%)
65% less capital invested
Capital invested by funds: $44.8M → $15.9M (-$29M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AF
Apexium Financial
Dallas,
Texas
|
+$443K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$199K |
| 3 |
AIP
Ahrens Investment Partners
Lafayette,
Louisiana
|
+$9.75K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$8.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$7.31M |
| 2 |
Morgan Stanley
New York
|
-$7.31M |
| 3 |
JP Morgan Chase
New York
|
-$6.11M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$6.09M |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$512K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Mirae Asset Global Investments
Seoul,
South Korea
| $7.44M | – | – | – |
|
|
2
Bank of America
Charlotte,
North Carolina
| $3.56M | -$6.09M | -250,000 | -63% |
|
|
3
Citigroup
New York
| $2.37M | -$7.31M | -300,000 | -75% |
|
|
4
Morgan Stanley
New York
| $1.19M | -$7.31M | -300,000 | -86% |
|
|
CGL
5
Clarius Group LLC
Seattle,
Washington
| $445K | – | – | – |
|
|
AF
6
Apexium Financial
Dallas,
Texas
| $431K | +$443K | +18,178 | New |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| $417K | +$199K | +8,182 | +87% |
|
|
AIP
8
Ahrens Investment Partners
Lafayette,
Louisiana
| $9K | +$9.75K | +400 | New |
|
|
9
UBS Group
Zurich,
Switzerland
| $8K | +$8.51K | +349 | New |
|
|
10
JP Morgan Chase
New York
| – | -$6.11M | -238,777 | Closed |
|
|
FTUS
11
Flow Traders U.S.
New York
| – | -$512K | -20,000 | Closed |
|
12
Osaic Holdings
Scottsdale,
Arizona
| – | -$5K | -200 | Closed |
|
IBBQ Hedge Fund Activity: Q4 2021 in Review
9 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Invesco NASDAQ Biotechnology ETF (IBBQ) for Q4 2021, worth a combined $15.9M — down 65% from $44.8M a quarter earlier.
Fund positioning in IBBQ was balanced in Q4 2021: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 3 trimmed.
The largest buyer was Apexium Financial, opening a new position worth an estimated $443K. The largest seller was Citigroup, cutting an estimated $7.31M.
- 9 institutional investors held Invesco NASDAQ Biotechnology ETF (IBBQ) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $15.9M of Invesco NASDAQ Biotechnology ETF stock for Q4 2021, down 65% quarter-over-quarter.
- 3 funds opened new Invesco NASDAQ Biotechnology ETF positions in Q4 2021 and 3 closed out, a net change of 0 holders.
- The largest Invesco NASDAQ Biotechnology ETF buyer in Q4 2021 was Apexium Financial, an estimated $443K added.
- The largest Invesco NASDAQ Biotechnology ETF seller in Q4 2021 was Citigroup, an estimated $7.31M sold.
Based on aggregated 13F filings for Q4 2021.